株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

POC (ポイントオブケア) 診断の世界市場:将来予測

Global Point Of Care Diagnostics Market Forecast 2019-2027

発行 Inkwood Research 商品コード 879085
出版日 ページ情報 英文 172 Pages
納期: 2-3営業日
価格
本日の銀行送金レート: 1USD=109.90円で換算しております。
Back to Top
POC (ポイントオブケア) 診断の世界市場:将来予測 Global Point Of Care Diagnostics Market Forecast 2019-2027
出版日: 2019年07月01日 ページ情報: 英文 172 Pages
概要

当レポートでは、世界のPOC (Point of Care) 診断用製品の市場の将来展望について分析し、製品の特性や市場の基本構造、主な促進・抑制要因、市場全体および処方形態別・エンドユーザー別・製品種類別・地域別の市場動向見通し (今後9年間分)、主要企業のプロファイルなどを調査しております。

第1章 分析範囲

第2章 分析手法

第3章 エグゼクティブ・サマリー

第4章 市場のダイナミクス

  • 市場の定義と範囲
  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 市場の課題

第5章 処方形態別の市場

  • 処方薬ベース
  • 市販薬 (OTC医薬品) ベース

第6章 エンドユーザー別の市場

  • 専門的診断選択
    • 病院/救急医療センター
    • 外来患者向け医療施設
    • 日帰り治療施設 (ASC)
  • 研究機関
  • 在宅治療
  • その他

第7章 製品種類別の市場

  • 血糖モニタリング・キット
  • 感染症検査キット
    • 肝炎検査キット
    • HIV検査キット
    • 呼吸器感染症検査キット
    • インフルエンザ検査キット
    • 医療関連感染症 (HAI) 検査キット
    • 性感染症 (STD) 検査キット
  • 妊娠・受胎能検査キット
    • 妊娠検査キット
    • 受胎能検査キット
  • 心血管代謝モニタリングキット
    • 心臓マーカーキット
    • HbA1c検査キット
    • 電解質・代謝物質検査キット
  • 尿検査キット
  • 凝固モニタリングキット
  • 腫瘍/がんマーカー検査キット
  • コレステロール検査キット
  • 薬物乱用 (DoA) 検査キット
  • 便潜血検査キット
  • その他

第8章 主な分析指標

  • ポーターのファイブフォース分析
  • 政治的・法的・経済的・技術的要因分析 (PESTEL)
  • 規制体制
  • 特許分析
  • POC (ポイントオブケア) 市場の分類
  • 市場機会マトリックス

第8章 地域別分析

  • 北米 (米国、カナダ)
  • 欧州 (ドイツ、フランス、英国、イタリア、スペインなど)
  • アジア太平洋地域 (日本、中国、インド、オーストラリア、韓国など)
  • 他の国々 (RoW:ラテンアメリカ、中東・アフリカ)

第10章 企業プロファイル

  • ABBOTT
  • BECTON DICKINSON AND COMPANY
  • BIOMERIEUX SA
  • BIO-RAD LABORATORIES, INC.
  • CARDINAL HEALTH INC.
  • CHEMBIO DIAGNOST ICS SYSTEMS, INC.
  • DANAHER CORPORATION
  • GENE POC
  • F. HOFFMANN-LA ROCHE LTD.
  • ORTHO CLINICAL DIAGNOSTICS
  • QUEST DIAGNOSTICS INC.
  • SIEMENS HEALTHINEERS
  • SIGHT DIAGNOSTICS LTD.
  • THERMO FISHER SCIENTIFIC INC.
  • TRINITY BIOTECH
  • TRIVITRON HEALTHCARE
目次
Product Code: 25641

KEY FINDINGS:

The global point of care diagnostic market is anticipated to grow at a CAGR of 9.28% between 2019 and 2027 to generate revenue of $57,482 million by 2027. The important drivers that have been enhancing the growth of the global point of care diagnostic market are the growing prevalence of chronic and infectious diseases and the rise in the implementation of healthcare reforms.

MARKET INSIGHTS:

The growing prevalence of chronic and infectious diseases, the rise in the implementation of healthcare reforms and the rising demand for decentralized chronic and infectious disease testing are drivinh the arket growth essentially.

The stringent regulation and insufficient reimbursement policies are the major factors hindering the point of care diagnostic market. The new POC product that is introduced in the market has to go through the regulatory approval process and meet the requirements of medical devices.

REGIONAL INSIGHTS:

Geographically, the global Point of care diagnostic market has been segmented on the basis of four major regions, namely, Asia Pacific, North America, Europe, and the Rest of World regional segment. Asia-Pacific market is anticipated to the fastest-growing region for the Point of care diagnostic market. Factors such as limited resource usability coupled with increasing prevalence rates, and technological advancements, are the major drivers in Asia Pacific segment of point of care testing market is expected to witness the fastest growth over the forecast period.

COMPETITIVE INSIGHTS:

The major companies operating in the market are Trinity Biotech, Trivitron Healthcare, Sight Diagnostics Ltd., Biomerieux SA, Becton Dickinson and Company, Ortho Clinical Diagnostics, Quest Diagnostics Inc., Siemens Healthineers, Thermo Fisher Scientific Inc., Chembio Diagnost ICS Systems, Inc., F. Hoffmann-La Roche Ltd., Bio-Rad Laboratories, Inc., Abbott, Gene POC, Danaher Corporation, and Cardinal Health Inc. The company profiles for each of these companies are thoroughly explored in the report.

TABLE OF CONTENTS

1. RESEARCH SCOPE

  • 1.1. STUDY GOALS
  • 1.2. SCOPE OF THE MARKET STUDY
  • 1.3. WHO WILL FIND THIS REPORT USEFUL?
  • 1.4. STUDY AND FORECASTING YEARS

2. RESEARCH METHODOLOGY

  • 2.1. SOURCES OF DATA
    • 2.1.1. SECONDARY DATA
    • 2.1.2. PRIMARY DATA
  • 2.2. TOP-DOWN APPROACH
  • 2.3. BOTTOM-UP APPROACH
  • 2.4. DATA TRIANGULATION

3. EXECUTIVE SUMMARY

  • 3.1. MARKET SUMMARY
  • 3.2. KEY FINDINGS
    • 3.2.1. INFECTIOUS DISEASE TESTING KIT IS THE FASTEST GROWING PRODUCT TYPE DURING THE FORECAST PERIOD
    • 3.2.2. PROFESSIONAL DIAGNOSTIC CENTERS ARE THE MAJOR END-USER IN POINT OF CARE MARKET
    • 3.2.3. PRESCRIPTION BASED DEVICES ARE THE FREQUENTLY USED MODE OF PRESCRIPTION

4. MARKET DYNAMICS

  • 4.1. MARKET SCOPE & DEFINITION
  • 4.2. MARKET DRIVERS
    • 4.2.1. GROWING PREVALENCE OF CHRONIC AND INFECTIOUS DISEASES
    • 4.2.2. RISE IN THE IMPLEMENTATION OF HEALTHCARE REFORMS
    • 4.2.3. RISING DEMAND FOR DECENTRALIZED CHRONIC AND INFECTIOUS DISEASE TESTING
  • 4.3. MARKET RESTRAINTS
    • 4.3.1. STRINGENT REGULATION
    • 4.3.2. INSUFFICIENT REIMBURSEMENT POLICIES
  • 4.4. MARKET OPPORTUNITIES
    • 4.4.1. REDUCTION IN THE HEALTHCARE COST FACILITATES
    • 4.4.2. RISING INCIDENCES AND PREVALENCE RATES OF VARIOUS INFECTIOUS DISEASES
    • 4.4.3. GROWING NUMBER OF SMARTPHONE EMPOWERS PATIENTS TO MONITOR THEIR CLINICAL CONDITION ONLINE
  • 4.5. MARKET CHALLENGES
    • 4.5.1. CHALLENGES RELATED TO THE EXECUTION OF HIGHLY SENSITIVE DEVICES
    • 4.5.2. VARIATION IN TEST RESULTS
    • 4.5.3. DIFFICULTIES ASSOCIATED IN DATA MANAGEMENT

5. MARKET BY MODE OF PRESCRIPTION

  • 5.1. PRESCRIPTION BASED DEVICES
  • 5.2. OTC BASED DEVICES

6. MARKET BY END-USER

  • 6.1. PROFESSIONAL DIAGNOSTIC CENTERS
    • 6.1.1. HOSPITALS/CRITICAL CARE CENTERS
    • 6.1.2. OUTPATIENT HEALTHCARE SETTINGS
    • 6.1.3. AMBULATORY CARE SETTINGS
  • 6.2. RESEARCH LABORATORIES
  • 6.3. HOME CARE
  • 6.4. OTHER END-USER

7. MARKET BY PRODUCT TYPE

  • 7.1. GLUCOSE MONITORING KITS
  • 7.2. INFECTIOUS DISEASES TESTING KITS
    • 7.2.1. HEPATITIS TESTING KITS
    • 7.2.2. HIV TESTING KITS
    • 7.2.3. RESPIRATORY INFECTIONS TESTING KITS
    • 7.2.4. INFLUENZA TESTING KITS
    • 7.2.5. HAIS
    • 7.2.6. STD TESTING KITS
    • 7.2.7. OTHER INFECTIOUS DISEASES TESTING KITS
  • 7.3. PREGNANCY AND FERTILITY TESTING KITS
    • 7.3.1. PREGNANCY TESTING KITS
    • 7.3.2. FERTILITY TESTING KITS
  • 7.4. HEMATOLOGY TESTING KITS
  • 7.5. CARDIOMETABOLIC MONITORING KITS
    • 7.5.1. CARDIAC MARKERS KITS
    • 7.5.2. HBA1C TESTING KITS
    • 7.5.3. ELECTROLYTES AND METABOLITES TESTING KITS
  • 7.6. URINALYSIS TESTING KITS
  • 7.7. COAGULATION MONITORING KITS
  • 7.8. TUMOR/CANCER MARKERS TESTING KITS
  • 7.9. CHOLESTEROL TESTING TRIPS
  • 7.10. DRUGS OF ABUSE TESTING KITS
  • 7.11. FECAL OCCULT TESTING KITS
  • 7.12. OTHER PRODUCT

8. KEY ANALYTICS

  • 8.1. PORTER'S FIVE FORCES MODEL
    • 8.1.1. THREAT OF NEW ENTRANTS
    • 8.1.2. THREAT OF SUBSTITUTE
    • 8.1.3. BARGAINING POWER OF BUYERS
    • 8.1.4. BARGAINING POWER OF SUPPLIERS
    • 8.1.5. THREAT OF COMPETITIVE RIVALRY
  • 8.2. POLITICAL & LEGAL, ECONOMIC AND TECHNOLOGICAL ANALYSIS
  • 8.3. REGULATORY FRAMEWORK
  • 8.4. PATENT ANALYSIS
  • 8.5. ETYMOLOGY OF POINT OF CARE MARKET
  • 8.6. OPPORTUNITY MATRIX

9. GEOGRAPHICAL ANALYSIS

  • 9.1. NORTH AMERICA
    • 9.1.1. THE UNITED STATES
    • 9.1.2. CANADA
  • 9.2. EUROPE
    • 9.2.1. GERMANY
    • 9.2.2. FRANCE
    • 9.2.3. THE UNITED KINGDOM
    • 9.2.4. ITALY
    • 9.2.5. SPAIN
    • 9.2.6. REST OF EUROPE
  • 9.3. ASIA PACIFIC
    • 9.3.1. JAPAN
    • 9.3.2. CHINA
    • 9.3.3. INDIA
    • 9.3.4. AUSTRALIA
    • 9.3.5. SOUTH KOREA
    • 9.3.6. REST OF ASIA PACIFIC
  • 9.4. REST OF WORLD
    • 9.4.1. LATIN AMERICA
    • 9.4.2. MIDDLE EAST AND AFRICA

10. COMPANY PROFILES

  • 10.1. ABBOTT
  • 10.2. BECTON DICKINSON AND COMPANY
  • 10.3. BIOMERIEUX SA
  • 10.4. BIO-RAD LABORATORIES, INC.
  • 10.5. CARDINAL HEALTH INC.
  • 10.6. CHEMBIO DIAGNOST ICS SYSTEMS, INC.
  • 10.7. DANAHER CORPORATION
  • 10.8. GENE POC
  • 10.9. F. HOFFMANN-LA ROCHE LTD.
  • 10.10. ORTHO CLINICAL DIAGNOSTICS
  • 10.11. QUEST DIAGNOSTICS INC.
  • 10.12. SIEMENS HEALTHINEERS
  • 10.13. SIGHT DIAGNOSTICS LTD.
  • 10.14. THERMO FISHER SCIENTIFIC INC.
  • 10.15. TRINITY BIOTECH
  • 10.16. TRIVITRON HEALTHCARE

TABLES LIST

  • TABLE 1: GLOBAL POINT OF CARE DIAGNOSTICS MARKET BY REGION 2019-2027 ($ MILLION)
  • TABLE 2: GLOBAL POINT OF CARE DIAGNOSTICS MARKET BY MODE OF PRESCRIPTION 2019-2027 ($ MILLION)
  • TABLE 3: GLOBAL PRESCRIPTION BASED DEVICES MARKET BY REGION 2019-2027 ($ MILLION)
  • TABLE 4: GLOBAL OTC BASED DEVICES MARKET BY REGION 2019-2027 ($ MILLION)
  • TABLE 5: GLOBAL POINT OF CARE DIAGNOSTICS MARKET BY END-USER 2019-2027 ($ MILLION)
  • TABLE 6: GLOBAL PROFESSIONAL DIAGNOSTIC CENTERS MARKET BY REGION 2019-2027 ($ MILLION)
  • TABLE 7: GLOBAL PROFESSIONAL DIAGNOSTIC CENTERS MARKET BY TYPE 2019-2027 ($ MILLION)
  • TABLE 8: GLOBAL RESEARCH LABORATORIES MARKET BY REGION 2019-2027 ($ MILLION)
  • TABLE 9: GLOBAL HOME CARE MARKET BY REGION 2019-2027 ($ MILLION)
  • TABLE 10: GLOBAL OTHER END-USER MARKET BY REGION 2019-2027 ($ MILLION)
  • TABLE 11: GLOBAL POINT OF CARE DIAGNOSTICS MARKET BY PRODUCT TYPE 2019-2027 ($ MILLION)
  • TABLE 12: GLOBAL GLUCOSE MONITORING KITS MARKET BY REGION 2019-2027 ($ MILLION)
  • TABLE 13: GLOBAL INFECTIOUS DISEASES TESTING KITS MARKET BY REGION 2019-2027 ($ MILLION)
  • TABLE 14: GLOBAL INFECTIOUS DISEASES TESTING KITS MARKET BY TYPE 2019-2027 ($ MILLION)
  • TABLE 15: GLOBAL PREGNANCY AND FERTILITY TESTING KITS MARKET BY REGION 2019-2027 ($ MILLION)
  • TABLE 16: GLOBAL PREGNANCY AND FERTILITY TESTING KITS MARKET BY TYPE 2019-2027 ($ MILLION)
  • TABLE 17: GLOBAL HEMATOLOGY TESTING KITS MARKET BY REGION 2019-2027 ($ MILLION)
  • TABLE 18: GLOBAL CARDIOMETABOLIC MONITORING KITS MARKET BY REGION 2019-2027 ($ MILLION)
  • TABLE 19: GLOBAL CARDIOMETABOLIC MONITORING KITS MARKET BY TYPE 2019-2027 ($ MILLION)
  • TABLE 20: GLOBAL URINALYSIS TESTING KITS MARKET BY REGION 2019-2027 ($ MILLION)
  • TABLE 21: GLOBAL COAGULATION MONITORING KITS MARKET BY REGION 2019-2027 ($ MILLION)
  • TABLE 22: GLOBAL TUMOR/CANCER MARKERS TESTING KITS MARKET BY REGION 2019-2027 ($ MILLION)
  • TABLE 23: GLOBAL CHOLESTEROL TESTING TRIPS MARKET BY REGION 2019-2027 ($ MILLION)
  • TABLE 24: GLOBAL DRUGS OF ABUSE TESTING KITS MARKET BY REGION 2019-2027 ($ MILLION)
  • TABLE 25: GLOBAL FECAL OCCULT TESTING KITS MARKET BY REGION 2019-2027 ($ MILLION)
  • TABLE 26: GLOBAL OTHER PRODUCT MARKET BY REGION 2019-2027 ($ MILLION)
  • TABLE 27: GLOBAL POINT OF CARE DIAGNOSTICS MARKET BY REGION 2019-2027 ($ MILLION)
  • TABLE 28: NORTH AMERICA POINT OF CARE DIAGNOSTICS MARKET BY COUNTRY 2019-2027 ($ MILLION)
  • TABLE 29: EUROPE POINT OF CARE DIAGNOSTICS MARKET BY COUNTRY 2019-2027 ($ MILLION)
  • TABLE 30: ASIA PACIFIC POINT OF CARE DIAGNOSTICS MARKET BY COUNTRY 2019-2027 ($ MILLION)
  • TABLE 31: REST OF WORLD POINT OF CARE DIAGNOSTICS MARKET BY REGION 2019-2027 ($ MILLION)

FIGURES LIST

  • FIGURE 1: GLOBAL POINT OF CARE DIAGNOSTICS MARKET 2019-2027 ($ MILLION)
  • FIGURE 2: GLOBAL POINT OF CARE DIAGNOSTICS MARKET SHARE BY MODE OF PRESCRIPTION 2018 & 2027 (%)
  • FIGURE 3: GLOBAL POINT OF CARE DIAGNOSTICS MARKET BY PRESCRIPTION BASED DEVICES 2019-2027 ($ MILLION)
  • FIGURE 4: GLOBAL POINT OF CARE DIAGNOSTICS MARKET BY OTC BASED DEVICES 2019-2027 ($ MILLION)
  • FIGURE 5: GLOBAL POINT OF CARE DIAGNOSTICS MARKET SHARE BY END-USER 2018 & 2027 (%)
  • FIGURE 6: GLOBAL POINT OF CARE DIAGNOSTICS MARKET BY PROFESSIONAL DIAGNOSTIC CENTERS 2019-2027 ($ MILLION)
  • FIGURE 7: GLOBAL PROFESSIONAL DIAGNOSTIC CENTERS MARKET BY HOSPITALS/CRITICAL CARE CENTERS 2019-2027 ($ MILLION)
  • FIGURE 8: GLOBAL PROFESSIONAL DIAGNOSTIC CENTERS MARKET BY OUTPATIENT HEALTHCARE SETTINGS 2019-2027 ($ MILLION)
  • FIGURE 9: GLOBAL PROFESSIONAL DIAGNOSTIC CENTERS MARKET BY AMBULATORY CARE SETTINGS 2019-2027 ($ MILLION)
  • FIGURE 10: GLOBAL POINT OF CARE DIAGNOSTICS MARKET BY RESEARCH LABORATORIES 2019-2027 ($ MILLION)
  • FIGURE 11: GLOBAL POINT OF CARE DIAGNOSTICS MARKET BY HOME CARE 2019-2027 ($ MILLION)
  • FIGURE 12: GLOBAL POINT OF CARE DIAGNOSTICS MARKET BY OTHER END-USER 2019-2027 ($ MILLION)
  • FIGURE 13: GLOBAL POINT OF CARE DIAGNOSTICS MARKET SHARE BY PRODUCT TYPE 2018 & 2027 (%)
  • FIGURE 14: GLOBAL POINT OF CARE DIAGNOSTICS MARKET BY GLUCOSE MONITORING KITS 2019-2027 ($ MILLION)
  • FIGURE 15: GLOBAL POINT OF CARE DIAGNOSTICS MARKET BY INFECTIOUS DISEASES TESTING KITS 2019-2027 ($ MILLION)
  • FIGURE 1: GLOBAL INFECTIOUS DISEASES TESTING KITS MARKET BY HEPATITIS TESTING KITS 2019-2027 ($ MILLION)
  • FIGURE 1: GLOBAL INFECTIOUS DISEASES TESTING KITS MARKET BY HIV TESTING KITS 2019-2027 ($ MILLION)
  • FIGURE 18: GLOBAL INFECTIOUS DISEASES TESTING KITS MARKET BY RESPIRATORY INFECTIONS TESTING KITS 2019-2027 ($ MILLION)
  • FIGURE 19: GLOBAL INFECTIOUS DISEASES TESTING KITS MARKET BY INFLUENZA TESTING KITS 2019-2027 ($ MILLION)
  • FIGURE 20: GLOBAL INFECTIOUS DISEASES TESTING KITS MARKET BY HAIS 2019-2027 ($ MILLION)
  • FIGURE 21: GLOBAL INFECTIOUS DISEASES TESTING KITS MARKET BY STDS TESTING KITS 2019-2027 ($ MILLION)
  • FIGURE 22: GLOBAL INFECTIOUS DISEASES TESTING KITS MARKET BY OTHER INFECTIOUS DISEASES TESTING KITS 2019-2027 ($ MILLION)
  • FIGURE 23: GLOBAL POINT OF CARE DIAGNOSTICS MARKET BY PREGNANCY AND FERTILITY TESTING KITS 2019-2027 ($ MILLION)
  • FIGURE 24: GLOBAL PREGNANCY AND FERTILITY TESTING KITS MARKET BY PREGNANCY TESTING KITS 2019-2027 ($ MILLION)
  • FIGURE 25: GLOBAL PREGNANCY AND FERTILITY TESTING KITS MARKET BY FERTILITY TESTING KITS 2019-2027 ($ MILLION)
  • FIGURE 26: GLOBAL POINT OF CARE DIAGNOSTICS MARKET BY HEMATOLOGY TESTING KITS 2019-2027 ($ MILLION)
  • FIGURE 27: GLOBAL POINT OF CARE DIAGNOSTICS MARKET BY CARDIOMETABOLIC MONITORING KITS 2019-2027 ($ MILLION)
  • FIGURE 28: GLOBAL CARDIOMETABOLIC MONITORING KITS MARKET BY CARDIAC MARKERS KITS 2019-2027 ($ MILLION)
  • FIGURE 29: GLOBAL CARDIOMETABOLIC MONITORING KITS MARKET BY HBA1C TESTING KITS 2019-2027 ($ MILLION)
  • FIGURE 30: GLOBAL CARDIOMETABOLIC MONITORING KITS MARKET BY ELECTROLYTES AND METABOLITES TESTING KITS 2019-2027 ($ MILLION)
  • FIGURE 31: GLOBAL POINT OF CARE DIAGNOSTICS MARKET BY URINALYSIS TESTING KITS 2019-2027 ($ MILLION)
  • FIGURE 32: GLOBAL POINT OF CARE DIAGNOSTICS MARKET BY COAGULATION MONITORING KITS 2019-2027 ($ MILLION)
  • FIGURE 33: GLOBAL POINT OF CARE DIAGNOSTICS MARKET BY TUMOR/CANCER MARKERS TESTING KITS 2019-2027 ($ MILLION)
  • FIGURE 34: GLOBAL POINT OF CARE DIAGNOSTICS MARKET BY CHOLESTEROL TESTING TRIPS 2019-2027 ($ MILLION)
  • FIGURE 35: GLOBAL POINT OF CARE DIAGNOSTICS MARKET BY DRUGS OF ABUSE TESTING KITS 2019-2027 ($ MILLION)
  • FIGURE 36: GLOBAL POINT OF CARE DIAGNOSTICS MARKET BY FECAL OCCULT TESTING KITS 2019-2027 ($ MILLION)
  • FIGURE 37: GLOBAL POINT OF CARE DIAGNOSTICS MARKET BY OTHER PRODUCT 2019-2027 ($ MILLION)
  • FIGURE 38: PORTER'S FIVE FORCE MODEL
  • FIGURE 39: GLOBAL POINT OF CARE DIAGNOSTICS MARKET REGIONAL OUTLOOK 2018 & 2027 (%)
  • FIGURE 40: THE UNITED STATES POINT OF CARE DIAGNOSTICS MARKET 2019-2027 ($ MILLION)
  • FIGURE 41: CANADA POINT OF CARE DIAGNOSTICS MARKET 2019-2027 ($ MILLION)
  • FIGURE 42: GERMANY POINT OF CARE DIAGNOSTICS MARKET 2019-2027 ($ MILLION)
  • FIGURE 43: FRANCE POINT OF CARE DIAGNOSTICS MARKET 2019-2027 ($ MILLION)
  • FIGURE 44: THE UNITED KINGDOM POINT OF CARE DIAGNOSTICS MARKET 2019-2027 ($ MILLION)
  • FIGURE 45: ITALY POINT OF CARE DIAGNOSTICS MARKET 2019-2027 ($ MILLION)
  • FIGURE 46: SPAIN POINT OF CARE DIAGNOSTICS MARKET 2019-2027 ($ MILLION)
  • FIGURE 47: REST OF EUROPE POINT OF CARE DIAGNOSTICS S MARKET 2019-2027 ($ MILLION)
  • FIGURE 48: JAPAN POINT OF CARE DIAGNOSTICS MARKET 2019-2027 ($ MILLION)
  • FIGURE 49: CHINA POINT OF CARE DIAGNOSTICS MARKET 2019-2027 ($ MILLION)
  • FIGURE 50: INDIA POINT OF CARE DIAGNOSTICS MARKET 2019-2027 ($ MILLION)
  • FIGURE 51: AUSTRALIA POINT OF CARE DIAGNOSTICS MARKET 2019-2027 ($ MILLION)
  • FIGURE 52: SOUTH KOREA POINT OF CARE DIAGNOSTICS MARKET 2019-2027 ($ MILLION)
  • FIGURE 53: REST OF ASIA PACIFIC POINT OF CARE DIAGNOSTICS MARKET 2019-2027 ($ MILLION)
  • FIGURE 54: LATIN AMERICA POINT OF CARE DIAGNOSTICS MARKET 2019-2027 ($ MILLION)
  • FIGURE 55: MIDDLE EAST AND AFRICA POINT OF CARE DIAGNOSTICS MARKET 2019-2027 ($ MILLION)
Back to Top